Skip to main content
. 2020 Dec 18;23(7):1113–1124. doi: 10.1093/neuonc/noaa284

Table 1.

Demographics of Patients Subdivided by the Age at Which They First Displayed NF2-Related Symptoms

Age of First NF2-Related Symptoms (Y) P Value P Value for Trend (Excluding Asymptomatic)
Asymptomatic <16 16-25 26-39 ≥40
Number 67 91 66 64 65 n/a n/a
Truncating mutation, n (%) 7 (10.5) 38 (41.8) 17 (25.8) 2 (3.1) 1 (1.5) <.001 <.001
Died, n (%) 2 (3.0) 23 (25.3) 13 (19.7) 10 (15.6) 12 (18.5) .006 .207
Died within 15 y of diagnosis, n (%) 1a (1.5) 11 (12.1) 6 (9.1) 5 (7.8) 7 (10.8) .182 .678
Mean age at death, y 33.1 31.9 37.5 55.3 72.7 <.001 <.001
Most common presenting symptoms, n (%)
1 n/a Vision loss, 21 (23.1) Hearing loss, 36 (54.5) Hearing loss, 40 (62.5) Hearing loss, 35 (53.9)
2 n/a Hearing loss, 19 (20.9) Weakness/wasting, seizures, headache, tinnitus, 4 (6.1) Pain, 5 (7.8) Pain, 5 (7.7)
3 n/a Weakness/ wasting, 14 (15.4) Weakness/ wasting, 3 (4.7) Weakness/wasting, headaches, poor balance, 4 (6.2)

Abbreviations: n, number; %, percentage.

aSuicide death.